No Data
No Data
Cybin | 6-K/A: Report of foreign private issuer (related to financial reporting)
Cybin | 6-K: Report of foreign private issuer (related to financial reporting)
Cybin | 40-F: Annual reports filed by certain Canadian issuers
Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development
Cybin Inc. (AMEX:CYBN) (CBOE: CYBN), a clinical-stage biopharmaceutical company focused on developing next-generation psychedelic treatments for mental health disorders, announced Wednesday its financ
Cybin 4Q Loss C$21M >CYBN
Cybin 4Q Loss C$21M >CYBN
Express News | Cybin Q4 Net Loss C$21M Vs. C$14M YoY, Cash Totaled C$209 Million As Of March 31, 2024
No Data
JESSE JAMES8832OP : finally green tho